Malignant breast myoepithelioma: A systematic review

El Zein, 2017, Metaplastic carcinoma of the breast is more aggressive than triple-negative breast cancer: a study from a single institution and review of literature, Clin Breast Cancer, 17, 382‑91, 10.1016/j.clbc.2017.04.009 Ong, 2018, Metaplastic breast cancer treatment and outcomes in 2500 patients: a retrospective analysis of a national oncology database, Ann Surg Oncol, 25, 2249‑60, 10.1245/s10434-018-6533-3 He, 2019, Prognosis in different subtypes of metaplastic breast cancer: a population-based analysis, Breast Cancer Res Treat, 173, 329‑41, 10.1007/s10549-018-5005-6 Nelson, 2015, Survival outcomes of metaplastic breast cancer patients: results from a US population-based analysis, Ann Surg Oncol, 22, 24‑31, 10.1245/s10434-014-3890-4 McCart Reed, 2019, Phenotypic and molecular dissection of metaplastic breast cancer and the prognostic implications, J Pathol, 247, 214‑27, 10.1002/path.5184 Pezzi, 2007, Characteristics and treatment of metaplastic breast cancer: analysis of 892 cases from the national cancer data base, Ann Surg Oncol, 14, 166‑73 Cimino-Mathews, 2016, A clinicopathologic analysis of 45 patients with metaplastic breast carcinoma, Am J Clin Pathol, 145, 365‑72, 10.1093/ajcp/aqv097 Tzanninis, 2016, Management and outcomes in metaplastic breast cancer, Clin Breast Cancer, 16, 437‑43, 10.1016/j.clbc.2016.06.002 Zhang, 2015, Clinicopathological features and prognosis of metaplastic breast carcinoma: experience of a major chinese cancer center, PLoS ONE, 10, 10.1371/journal.pone.0131409 Han, 2019, Metaplastic breast carcinoma: a clinical-pathologic study of 97 cases with subset analysis of response to neoadjuvant chemotherapy, Mod Pathol Off J U S Can Acad Pathol Inc, 32, 807‑16 Rakha, 2015, Prognostic factors in metaplastic carcinoma of the breast: a multi-institutional study, Br J Cancer, 112, 283‑9, 10.1038/bjc.2014.592 Song, 2013, Unique clinicopathological features of metaplastic breast carcinoma compared with invasive ductal carcinoma and poor prognostic indicators, World J Surg Oncol, 11, 129, 10.1186/1477-7819-11-129 Leyrer, 2017, Predictive factors on outcomes in metaplastic breast cancer, Breast Cancer Res Treat, 165, 499‑504, 10.1007/s10549-017-4367-5 Tseng, 2011, Metaplastic breast cancer: to radiate or not to radiate?, Ann Surg Oncol, 18, 94‑103, 10.1245/s10434-010-1198-6 Haque, 2018, Metaplastic breast cancer: practice patterns, outcomes, and the role of radiotherapy, Ann Surg Oncol, 25, 928‑36, 10.1245/s10434-017-6316-2 Paul Wright, 2014, Hormone receptor status does not affect prognosis in metaplastic breast cancer: a population-based analysis with comparison to infiltrating ductal and lobular carcinomas, Ann Surg Oncol, 21, 3497‑503, 10.1245/s10434-014-3782-7 Takala, 2019, Metaplastic carcinoma of the breast: Prognosis and response to systemic treatment in metastatic disease, Breast J, 25, 418‑24, 10.1111/tbj.13234 Al Sayed, 2006, Metaplastic carcinoma of the breast clinical presentation, treatment results and prognostic factors, Acta Oncol Stockh Swed, 45, 188‑95 Hennessy, 2006, Biphasic metaplastic sarcomatoid carcinoma of the breast, Ann Oncol Off J Eur Soc Med Oncol, 17, 605‑13 Al-Hilli, 2019, Metaplastic breast cancer has a poor response to neoadjuvant systemic therapy, Breast Cancer Res Treat, 176, 709‑16, 10.1007/s10549-019-05264-2